Taking everything into account, CHR scores 5 out of 10 in our fundamental rating. CHR was compared to 70 industry peers in the Interactive Media & Services industry. CHR has an excellent financial health rating, but there are some minor concerns on its profitability. CHR is valued correctly, but it does not seem to be growing.

Quickly go to:

1. Profitability

2. Health

3. Growth

4. Valuation

5. Dividend

1. Profitability

1.1 Basic Checks

CHR had positive earnings in the past year.
CHR had a positive operating cash flow in the past year.
Each year in the past 5 years CHR has been profitable.
In the past 5 years CHR always reported a positive cash flow from operatings.

1.2 Ratios

With a decent Return On Assets value of 6.82%, CHR is doing good in the industry, outperforming 80.00% of the companies in the same industry.
CHR's Return On Equity of 7.68% is fine compared to the rest of the industry. CHR outperforms 80.00% of its industry peers.
CHR has a Return On Invested Capital of 6.27%. This is in the better half of the industry: CHR outperforms 75.71% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for CHR is below the industry average of 13.53%.

		Industry Rank	Sector Rank
ROA	6.82%
ROE	7.68%
ROIC	6.27%

ROA(3y)9.95%

ROA(5y)13.67%

ROE(3y)11.67%

ROE(5y)17.03%

ROIC(3y)9%

ROIC(5y)13.46%

1.3 Margins

CHR has a better Profit Margin (16.81%) than 84.29% of its industry peers.
In the last couple of years the Profit Margin of CHR has declined.
The Operating Margin of CHR (17.47%) is better than 84.29% of its industry peers.
In the last couple of years the Operating Margin of CHR has declined.
CHR has a better Gross Margin (71.95%) than 64.29% of its industry peers.
CHR's Gross Margin has declined in the last couple of years.

		Industry Rank	Sector Rank
OM	17.47%
PM (TTM)	16.81%
GM	71.95%

OM growth 3Y-9.83%

OM growth 5YN/A

PM growth 3Y-8.55%

PM growth 5YN/A

GM growth 3Y-1.72%

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CHR is still creating some value.
Compared to 1 year ago, CHR has more shares outstanding
The number of shares outstanding for CHR has been reduced compared to 5 years ago.
The debt/assets ratio for CHR is higher compared to a year ago.

2.2 Solvency

CHR has an Altman-Z score of 4.65. This indicates that CHR is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 4.65, CHR is doing good in the industry, outperforming 78.57% of the companies in the same industry.
CHR has a debt to FCF ratio of 1.05. This is a very positive value and a sign of high solvency as it would only need 1.05 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 1.05, CHR is in the better half of the industry, outperforming 80.00% of the companies in the same industry.
CHR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
CHR has a Debt to Equity ratio of 0.00. This is in the better half of the industry: CHR outperforms 67.14% of its industry peers.

		Industry Rank	Sector Rank
Debt/Equity	0
Debt/FCF	1.05
Altman-Z	4.65

ROIC/WACC0.86

WACC7.31%

2.3 Liquidity

CHR has a Current Ratio of 8.29. This indicates that CHR is financially healthy and has no problem in meeting its short term obligations.
CHR's Current ratio of 8.29 is amongst the best of the industry. CHR outperforms 92.86% of its industry peers.
CHR has a Quick Ratio of 8.29. This indicates that CHR is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of CHR (8.29) is better than 92.86% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	8.29
Quick Ratio	8.29

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for CHR have decreased strongly by -33.54% in the last year.
CHR shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 90.58% yearly.
CHR shows a decrease in Revenue. In the last year, the revenue decreased by -5.65%.
The Revenue has been decreasing by -1.28% on average over the past years.

EPS 1Y (TTM)-33.54%

EPS 3Y-22.48%

EPS 5Y90.58%

EPS Q2Q%-15.99%

Revenue 1Y (TTM)-5.65%

Revenue growth 3Y-1.28%

Revenue growth 5YN/A

Sales Q2Q%-0.09%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 0.57, the valuation of CHR can be described as very cheap.
CHR's Price/Earnings ratio is rather cheap when compared to the industry. CHR is cheaper than 98.57% of the companies in the same industry.
CHR's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 28.32.

		Industry Rank	Sector Rank
PE	0.57
Fwd PE	N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of CHR indicates a somewhat cheap valuation: CHR is cheaper than 70.00% of the companies listed in the same industry.